Editorial: Advances in drug-induced diseases

Editorial: Advances in drug-induced diseases

Bibliographic Details
Main Authors:	Yao Liu, Jia-bo Wang, Linan Zeng, Maxine Gossell-Williams, Patricia Moriel, Miao Yan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Series:	Frontiers in Pharmacology
Subjects:	drug-induced diseases drug safety FAERS adverse drug reactions Editorial
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1193099/full

Similar Items

Comprehensive Study of Drug-Induced Pruritus Based on Adverse Drug Reaction Report Database
by: Yuriko Nakao, et al.
Published: (2023-10-01)

Rhabdomyolysis associated with newer-generation anti-seizure medications (ASMs): a real-world retrospective and pharmacovigilance study
by: Zhenzhen Deng, et al.
Published: (2023-10-01)

Reverse translation of adverse event reports paves the way for de-risking preclinical off-targets
by: Mateusz Maciejewski, et al.
Published: (2017-08-01)

The benefits of data mining
by: Audrey Bone, et al.
Published: (2017-08-01)

Depression Events Associated with Proton-Pump Inhibitors in Postmarketing Drug Surveillance Data
by: Tigran Makunts, et al.
Published: (2023-08-01)

Editorial: Therapeutic drug monitoring and clinical toxicology of anti-cancer drugs
by: Yao Liu, et al.
Published: (2022-10-01)

Adverse Events Associated with Nirmatrelvir/Ritonavir: A Pharmacovigilance Analysis Based on FAERS
by: Meng Li, et al.
Published: (2022-11-01)

Drug-induced parkinsonism
by: T. M. Ostroumova, et al.
Published: (2021-12-01)

Causative drugs for drug-induced cutaneous reactions in central China: a 608-case analysis,
by: Jun Zhao, et al.
Published: (2020-02-01)

MONITORING OF DRUG SAFETY IN CLINICAL PRACTICE
by: N. V. Verlan, et al.
Published: (2017-02-01)

Trends in qualifying biomarkers in drug safety. Consensus of the 2011 meeting of the Spanish Society of Clinical Pharmacology.
by: José A.G. eAgúndez, et al.
Published: (2012-01-01)

Analysis of post-market adverse events of istradefylline: a real-world study base on FAERS database
by: Ying Jiang, et al.
Published: (2024-04-01)

Signal mining and risk analysis of Alprazolam adverse events based on the FAERS database
by: Feng Huang, et al.
Published: (2024-03-01)

A Standardized Dataset of a Spontaneous Adverse Event Reporting System
by: Mohammad Ali Khaleel, et al.
Published: (2022-02-01)

Clinical and pharmacological monitoring of drug safety in pediatrics
by: N. V. Verlan, et al.
Published: (2016-05-01)

Editorial: Pharmacovigilance and drug repositioning research using pharmacoepidemiology
by: Yoshihiro Noguchi, et al.
Published: (2023-06-01)

Hepatic impairment as a risk factor of adverse drug reactions
by: Olga D. Ostroumova, et al.
Published: (2021-12-01)

Platinum drugs-related safety profile: The latest five-year analysis from FDA adverse event reporting system data
by: Guowen Feng, et al.
Published: (2023-01-01)

Drug-induced hypocalcemia
by: A. I. Listratov, et al.
Published: (2021-10-01)

A real-world pharmacovigilance analysis of FDA adverse event reporting system database for upadacitinib
by: Yan Wu, et al.
Published: (2023-08-01)

Monitoring of drug safety
by: B. K. Romanov, et al.
Published: (2022-06-01)

Pharmacogenetics and predictive testing of drug hypersensitivity reactions
by: Ruwen Boehm, et al.
Published: (2016-10-01)

Do antibody–drug conjugates increase the risk of sepsis in cancer patients? A pharmacovigilance study
by: Shuang Xia, et al.
Published: (2022-11-01)

Hepatotoxicity reports in the FDA adverse event reporting system database: A comparison of drugs that cause injury via mitochondrial or other mechanisms
by: Payal Rana, et al.
Published: (2021-12-01)

Cardiotoxicity Induced by Immune Checkpoint Inhibitors: A Pharmacovigilance Study From 2014 to 2019 Based on FAERS
by: Chenxin Chen, et al.
Published: (2021-02-01)

Editorial: Therapeutic drug monitoring and clinical toxicology of anti-cancer drugs, volume II
by: Miao Yan, et al.
Published: (2023-03-01)

Advanced Age as a Risk Factor of Drug-Induced Diseases
by: D. A. Sychev, et al.
Published: (2021-03-01)

Comparing epidemiological methods in detecting drug safety signal in IRAN
by: G Shalviri, et al.
Published: (2005-12-01)

Drugs associated with DIP
by: T. M. Ostroumova, et al.
Published: (2021-12-01)

Drug-induced bradycardia as a medical and social problem: data from the Cardiac Drug Overdoses Hospital Registry (STORM)
by: N. N. Nikulina, et al.
Published: (2020-08-01)

Arrhythmic events associated with immune checkpoint inhibitors therapy: A real‐world study based on the Food and Drug Administration Adverse Event Reporting System database
by: Yunwei Liu, et al.
Published: (2023-03-01)

Drug-induced tremor
by: T. M. Ostroumova, et al.
Published: (2022-04-01)

The Association between Molecular Initiating Events and Drug-Induced Hiccups
by: Ryuichiro Hosoya, et al.
Published: (2024-03-01)

Antineoplastic agents associated with the development of drug-induced pancreatitis
by: N. A. Arablinskiy, et al.
Published: (2021-08-01)

Analysis of spontaneous reporting of suspected adverse drug reactions for non-analgesic over-the-counter drugs from 2008 to 2017
by: Josipa Bukic, et al.
Published: (2019-10-01)

Pharmacovigilance: Empowering healthcare professionals
by: Mugoša Snežana S., et al.
Published: (2015-01-01)

Opioids and frequency counts in the US Food and Drug Administration Adverse Event Reporting System (FAERS) database: a quantitative view of the epidemic
by: Veronin MA, et al.
Published: (2019-08-01)

Drug-induced cognitive impairment
by: O. D. Ostroumova, et al.
Published: (2020-06-01)

Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients
by: Alan O. Vázquez-Alvarez, et al.
Published: (2017-12-01)

From genomic spectrum of NTRK genes to adverse effects of its inhibitors, a comprehensive genome-based and real-world pharmacovigilance analysis
by: Zhiwei Cui, et al.
Published: (2024-01-01)